|
End-of-day quote
Other stock markets
|
||
| - LVL | - |
|
| 22-01-07 | Delisting of AS "Olainfarm” shares from the Baltic Main list | AQ |
| 22-01-06 | Notification about results of final buy-back of shares | AQ |
| 21-12-30 | Notification about final share buy-back | AQ |
| 21-12-28 | Correction: Regarding results of a share buy-back offer | AQ |
| 21-12-28 | On substantial participation (4) - specified | AQ |
| Manager | Title | Age | Since |
|---|---|---|---|
Juris Hmelnickis
CEO | Chief Executive Officer | 46 | 2025-12-31 |
Janis Leimanis
DFI | Director of Finance/CFO | 56 | - |
| Chief Tech/Sci/R&D Officer | - | 2009-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 63 | 2021-06-18 | |
Janis Buks
CHM | Chairman | - | 2022-08-31 |
Roberts Tavjevs
BRD | Director/Board Member | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.15% | +0.75% | +16.13% | +73.62% | 49.38B | |
| +0.53% | +2.75% | +62.41% | +111.34% | 36.35B | |
| +2.50% | +0.84% | -8.10% | +22.65% | 11.87B | |
| -0.81% | -3.84% | +12.15% | +71.62% | 11.53B | |
| -0.37% | 0.00% | +37.53% | +136.73% | 8.99B | |
| -0.92% | +0.83% | +46.04% | -7.27% | 7B | |
| -0.26% | -0.51% | +12.15% | +33.71% | 6.76B | |
| -0.52% | -2.56% | +1.87% | +173.50% | 6.46B | |
| +3.51% | -10.69% | -31.55% | +1.09% | 5.49B | |
| Average | +0.45% | -1.06% | +16.51% | +68.55% | 15.98B | |
| Weighted average by Cap. | +0.37% | +0.29% | +25.65% | +78.63% |
Employees
-
Sector
Pharmaceuticals
- Stock Market
- Stocks
- OLF1R Stock
- OLF1R Stock
Select your edition
All financial news and data tailored to specific country editions
